Translation of "Low bleed" in German

Such a property is advantageous for low or no bleed prepreg systems for use as honeycomb skins.

Reproducibility in the production of low--or no--bleed systems is difficult to achieve.

The modified hardener allows reproducible production of no--or low--bleed prepregs for use with or without honeycomb.

The addition of softeners does in fact improve the flawless incorporation of inorganic solids but the softener can, despite its low vapor pressure, bleed and volatize during the intensive rinsing with gas in the application of the membrane.

Fua made ??purchases in the method nape of the neck is low bleeding rates .

Eliquis should be discontinued at least 24 hours prior to elective surgery or invasive procedures with a low risk of bleeding.

It is used in those patients who have at least one risk factor for vascular events such as a heart attack or stroke, cannot take vitamin K antagonists (other medicines that prevent blood clots) and are at low risk of bleeding.

It is used in patients who have at least one risk factor for events such as a heart attack or stroke, cannot take vitamin-K antagonists (other medicines that prevent blood clots) and are at low risk of bleeding.

Prevention of atherothrombotic and thromboembolic events in atrial fibrillation In adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with Vitamin K antagonists (VKA) and who have a low bleeding risk, clopidogrel is indicated in combination with ASA for the prevention of atherothrombotic and thromboembolic events, including stroke.

Adults/adolescents who had a low bleeding rate of 0-2 bleeding episodes during the last 6 months and had obtained at least 50 doses of Esperoct had the option of being randomised to prophylaxis treatment every 7 days (75 IU/kg every 7 days) or every 4 days (50 IU/kg every 4 days).

Previously known as Clopidogrel Winthrop events such as a heart attack or stroke, cannot take vitamin K antagonists (other medicines that prevent blood clots) and are at low risk of bleeding.

Eligible patients were scheduled to undergo their procedure (low bleeding risk procedures, such as endoscopy and colonoscopy (60.8%); moderate bleeding risk, such as liver biopsy and chemoembolization for HCC (17.2%); or high bleeding risk, such as dental procedures and radiofrequency ablation (22.1%)) 5 to 8 days after their last dose of treatment.

In adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with Vitamin K antagonists (VKA) and who have a low bleeding risk, clopidogrel is indicated in combination with ASA for the prevention of atherothrombotic and thromboembolic events, including stroke.

Release of the ester and formation of free norethisterone take place for up to 5 days at almost constant rate, then become slightly greater up to the 11th day, drop gradually down to the initial level up to the 18th day, and reach values, after 28 days, that are so low that withdrawal bleeding occurs.

The colourations obtained have high purity and high saturation and are distinguished by good resistance, in particular to heat and light, and by their low bleeding tendency.

AF patients on rivaroxaban demonstrated a numerically lower risk of cardiovascular events (0.51% vs. 1.02%) compared to VKA, as well as a reassuring bleeding profile with a low major bleeding incidence risk (0.61% vs. 0.8%).

Another probable reason is poor placentation, which results in weak vessels that could tear under pressure and lead to low pressure bleeding.

Both rivaroxaban dosages demonstrated comparable and low major bleeding rates (the principal safety outcome) on the same level as aspirin therapy.

This low bleeding tendency caused by the substance is of great advantage for use in humans, particularly in patients with increased risk of bleeding.